Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function (Q34005353)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function |
scientific article |
Statements
1 reference
Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function (English)
1 reference
N V Ermolova
1 reference
L Martinez
1 reference
S A Vetrone
1 reference
M C Jordan
1 reference
K P Roos
1 reference
H L Sweeney
1 reference
M J Spencer
1 reference
26 April 2014
1 reference
1 reference
24
1 reference
583-595
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference